Articles Vol. 63 No. 4 (2022) 08/08/2022

ASSESSMENT OF KI-67 EXPRESSION IN HISTOPATHOLOGICAL SUBTYPES NON-HODGKIN'S B-CELL LYMPHOMA

Nguyen Khac Tuyen1,2, Dau Van Nhu1,2, Nguyen Cong Truong1,2, Tran Viet Hieu1,2, Nguyen Tien Dung1,2, Hoang Thi Lam1,2, Le Thi Linh3,4, Tran Ngoc Dung5,6
1 Military Hospital 175
2 Bệnh viện Quân y 175
3 Oncology Hospital - Ho Chi Minh City
4 Bệnh viện Ung Bướu thành phố Hồ Chí Minh
5 Military Hospital 103
6 Bệnh viện Quân y 103
Corresponding author: khactuyenqy@gmail.com
DOI: 10.52163/yhc.v63i4.365
21 Views
0 Downloads
Abstract

Objective: Histopathology classification of non-Hodgkin’s lymphoma (NHL) B-cell lineage and
evaluation of the immunohistochemical expression of Ki67 marker in histopathological subtypes
Non-Hodgkin’s B-cell lymphoma.
Matherial and Methods: A cross-sectional study of formalin-fixed paraffin-embedded samples
of 69 patients were confirmed as non-Hodgkin lymphoma B-cell (NHL) by histopathological and
immunohistochemistry techniques from January 2018 to January 2021, at Military Hospital 103.
Comment on histopathological characteristics, immunohistochemical expression marker and the
collected data analysis.
Result: Diffuse large B-cell lymphoma is the most common histopathologic subtype (76.80%), with
the average expressional value of Ki67 is 62.9 ± 14.7, the lowest value is 20, the highest is 90. The
Ki67 index of the FL, SLL/CLL, and MCL subtypes ranges from 20-30%, while the MZL has a Ki67
value ranging from 5-80%.
Conclusion: The Ki67 marker was expressed at a high rate in diffuse large B-cell lymphoma,
especially at a high level (≥65%) in most of the non-germinal center group.

References
[1]
GLOBOCAN, International Agence on Cancer Google Scholar
[2]
Research, 2018. Google Scholar
[3]
Steven HS, Elias C, Stefano AP et al., WHO Google Scholar
[4]
Classification of Tumours of Haematopoietic and Google Scholar
[5]
Lymphoid Tissues, IARC Lyon 2016, 2017. Google Scholar
[6]
Christine PH, Dennis DW, Timothy CG et al., Google Scholar
[7]
Confirmation of the molecular classification Google Scholar
[8]
of diffuse large B-cell lymphoma by Google Scholar
[9]
immunohistochemistry using a tissue microarray, Google Scholar
[10]
Blood, 2004; 103(1); 275–282. Google Scholar
[11]
TuyenPV,KhuyDM,HungNV,Histopathological Google Scholar
[12]
classification of B cell non-Hodgkin lymphoma Google Scholar
[13]
according to WHO 2008, Viet nam Medical Google Scholar
[14]
Journal, 2018; 128-133. Google Scholar
[15]
Smith A, Crouch S, Lax S et al., Lymphoma Google Scholar
[16]
incidence, survival and prevalence 2004–2014: Google Scholar
[17]
sub-type analyses from the UK’s Haematological Google Scholar
[18]
Malignancy Research Network, British journal of Google Scholar
[19]
cancer, 2015; 112(9); 1575-1584. Google Scholar
[20]
Michael F, James N, Mark AL et al., Comparative Google Scholar
[21]
immunohistochemical analysis of pediatric Google Scholar
[22]
Burkitt lymphoma and diffuse large B-cell44 Google Scholar
[23]
N.K. Tuyen et al. / Vietnam Journal of Community Medicine, Vol 63, No 4 (2022) 38-44 Google Scholar
[24]
lymphoma, Am J Clin Pathol, 2004; 121(3); Google Scholar
[25]
[26]
Mingyang L, Yixiong L, Yingmei W et al., Google Scholar
[27]
Anaplastic variant of diffuse large B-cell Google Scholar
[28]
lymphoma displays intricate genetic alterations Google Scholar
[29]
and distinct biological features, The American Google Scholar
[30]
journal of surgical pathology, 2017; 41(10); Google Scholar
[31]
[32]
Joy FK, John TL, A Practical Approach to Google Scholar
[33]
Diagnosis of B-Cell Lymphomas With Diffuse Google Scholar
[34]
Large Cell Morphology, Archives of Pathology Google Scholar
[35]
& Laboratory Medicine, 2020; 144(2); 160-167. Google Scholar
[36]
Hee YN, Ji-Young C, Sun AS et al., Correlation Google Scholar
[37]
of Ki 67 proliferative index with clinical and Google Scholar
[38]
pathological features on tissue sections of non Google Scholar
[39]
Hodgkins lymphoma by immunostaining, JPMAJournal of the Pakistan Medical Association, Google Scholar
[40]
; 61(8); 748. Google Scholar